ada standards of care 2025 glp-1 dpp-4 combination not recommended guidelines dpp4 and glp 1 in Diabetes Must read for all doctors ▪️ Cardiovascular risk: Use RA or SGLT2 inhibitors for glycemic control & cardiovascular risk 𝐋𝐚𝐭𝐞𝐬𝐭 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 𝐃𝐏𝐏-𝟒 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬

The really profound thing, he said, was to make the next leap and ask, What does GLP-1 actually do? There were a couple of groups of researchers, some in Boston and some in Denmark, who jumped

Less muscle means a slower metabolism, even at the same body weight

Protein becomes critically important during GLP-1 therapy because rapid weight lossparticularly when exceeding 12 pounds per weekincreases the risk of losing muscle mass alongside fat tissue

Some patients regain weight after stopping treatment, especially without continued nutrition, activity, and lifestyle support

When gut health is properly addressed it allows for improved bodily functioning overall ( Modified GRF 1-29 vs CJC 1295 Without DAC Whats interesting about modified GRF 1-29 is that it has nearly identical effects to another very popular peptide CJC 1295 without DAC

Doses above recommended levels have not been shown to cause harm